IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 186 filers reported holding IMMUNOGEN INC in Q1 2020. The put-call ratio across all filers is 0.61 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $54,000 | -21.7% | 15,000 | 0.0% | 0.02% | -25.0% |
| Q2 2020 | $69,000 | +35.3% | 15,000 | 0.0% | 0.02% | +26.3% |
| Q1 2020 | $51,000 | -33.8% | 15,000 | 0.0% | 0.02% | -26.9% |
| Q4 2019 | $77,000 | +113.9% | 15,000 | 0.0% | 0.03% | +100.0% |
| Q3 2019 | $36,000 | +9.1% | 15,000 | 0.0% | 0.01% | +8.3% |
| Q2 2019 | $33,000 | -19.5% | 15,000 | 0.0% | 0.01% | -20.0% |
| Q1 2019 | $41,000 | -43.1% | 15,000 | 0.0% | 0.02% | -50.0% |
| Q4 2018 | $72,000 | -49.3% | 15,000 | 0.0% | 0.03% | -47.4% |
| Q3 2018 | $142,000 | -2.7% | 15,000 | 0.0% | 0.06% | -9.5% |
| Q2 2018 | $146,000 | -7.6% | 15,000 | 0.0% | 0.06% | -8.7% |
| Q1 2018 | $158,000 | +64.6% | 15,000 | 0.0% | 0.07% | +64.3% |
| Q4 2017 | $96,000 | -16.5% | 15,000 | 0.0% | 0.04% | -19.2% |
| Q3 2017 | $115,000 | +7.5% | 15,000 | 0.0% | 0.05% | 0.0% |
| Q2 2017 | $107,000 | – | 15,000 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 17,503,417 | $277,779,228 | 13.22% |
| Fairmount Funds Management LLC | 5,929,592 | $94,102,625 | 11.32% |
| CM Management, LLC | 500,000 | $7,935,000 | 8.42% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,307,435 | $20,748,993 | 6.29% |
| Altium Capital Management LP | 725,000 | $11,505,750 | 6.00% |
| RA Capital Management | 13,322,288 | $211,424,711 | 4.16% |
| TANG CAPITAL MANAGEMENT LLC | 1,500,000 | $23,805,000 | 3.36% |
| BRIDGER MANAGEMENT, LLC | 467,220 | $7,414,781 | 2.73% |
| Birchview Capital, LP | 190,000 | $3,015,300 | 2.57% |
| Boxer Capital, LLC | 2,961,000 | $46,991,070 | 2.50% |